Disease Prevention Related News

Oxitec’s Friendly™ Aedes Mosquito Receives Positive Evaluation for European Standard in relation to Human Health and the Environment

OXFORD, England, July 6, 2017 /PRNewswire/ -- The National Institute of Public Health and the Environment (RIVM) in the Netherlands today published its "Technical evaluation of a potential release of OX513A Aedes aegypti mosquitoes on the island of Saba", which positively concludes a vector [...]

By | July 10th, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Digital-to-Biological Converter for On-Demand Production of Biologics Developed by Synthetic Genomics, Inc.

SAN DIEGO, May 29, 2017 — Synthetic Genomics, Inc. announced today the publication of a peer reviewed article describing the development and operation of its digital-to-biological converter (DBC) prototype that produced biologic compounds on-demand without any human intervention. The DBC [...]

Oxitec’s Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project

Piracicaba, March 30th, 2017 - Oxitec and Piracicaba City Hall announced today new results from the Friendly™ Aedes project in the CECAP/Eldorado district and the first results in the São Judas neighborhood in the city’s central region. In CECAP/Eldorado, Friendly™ [...]

By | April 2nd, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India

Dawalwadi (Jalna), India, and Oxford, UK, January 23rd, 2017 - Gangabishan Bhikulal Investment and Trading Limited (GBIT) and Oxitec announced today the launch of the Friendly™ Aedes project in Dawalwadi, India. Outdoor caged trials of Oxitec’s Friendly™ Aedes mosquito have [...]

By | January 24th, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Prokarium and Probiomed in UK-Mexico collaboration to scale-up manufacture of thermostable vaccines with a focus on diarrhoea

Keele, UK and Mexico City, MX, 4th January 2017. Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The [...]

By | January 4th, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based Monoclonal Antibodies Against Zika Virus

PLYMOUTH MEETING, Pa., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has been awarded a $6.1 million sub-grant through The Wistar Institute to develop a DNA-based monoclonal antibody designed to provide a fast-acting treatment against [...]